These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 8997600)
21. Selective blockade of drug-induced place preference conditioning by ACPC, a functional NDMA-receptor antagonist. Papp M; Gruca P; Willner P Neuropsychopharmacology; 2002 Nov; 27(5):727-43. PubMed ID: 12431848 [TBL] [Abstract][Full Text] [Related]
22. Blockade of the acquisition of ethanol-induced conditioned place preference by N-methyl-D-aspartate receptor antagonists. Biała G; Kotlińska J Alcohol Alcohol; 1999; 34(2):175-82. PubMed ID: 10344778 [TBL] [Abstract][Full Text] [Related]
23. The rewarding properties of NMDA and MK-801 (dizocilpine) as indexed by the conditioned place preference paradigm. Panos JJ; Rademacher DJ; Renner SL; Steinpreis RE Pharmacol Biochem Behav; 1999 Nov; 64(3):591-5. PubMed ID: 10548276 [TBL] [Abstract][Full Text] [Related]
24. The effects of NMDA receptor antagonists at anticonvulsive doses on the performance of rats in the water maze task. Ylinen A; Pitkänen M; Sirviö J; Hartikainen T; Sivenius J; Koivisto E; Riekkinen PJ Eur J Pharmacol; 1995 Feb; 274(1-3):159-65. PubMed ID: 7768268 [TBL] [Abstract][Full Text] [Related]
25. Site-specific NMDA receptor antagonists produce differential effects on cocaine self-administration in rats. Hyytiä P; Bäckström P; Liljequist S Eur J Pharmacol; 1999 Jul; 378(1):9-16. PubMed ID: 10478559 [TBL] [Abstract][Full Text] [Related]
26. Comparison of competitive and uncompetitive NMDA receptor antagonists with regard to monoaminergic neuronal activity and behavioural effects in rats. Löscher W; Annies R; Hönack D Eur J Pharmacol; 1993 Oct; 242(3):263-74. PubMed ID: 7904243 [TBL] [Abstract][Full Text] [Related]
27. Regional alterations in brain amino acids after administration of the N-methyl-D-aspartate receptor antagonists MK-801 and CGP 39551 in rats. Löscher W; Hönack D; Fassbender CP Neurosci Lett; 1991 Mar; 124(1):115-8. PubMed ID: 1677457 [TBL] [Abstract][Full Text] [Related]
28. Adaptive changes in the N-methyl-D-aspartate receptor complex after chronic treatment with imipramine and 1-aminocyclopropanecarboxylic acid. Nowak G; Trullas R; Layer RT; Skolnick P; Paul IA J Pharmacol Exp Ther; 1993 Jun; 265(3):1380-6. PubMed ID: 8099620 [TBL] [Abstract][Full Text] [Related]
29. Acute or prolonged exposure to 1-aminocyclopropanecarboxylic acid protects spinal neurons against NMDA toxicity. Lin Y; Long JB Eur J Pharmacol; 1996 Dec; 318(2-3):491-6. PubMed ID: 9016943 [TBL] [Abstract][Full Text] [Related]
30. Rat pup isolation calls are reduced by functional antagonists of the NMDA receptor complex. Winslow JT; Insel TR; Trullas R; Skolnick P Eur J Pharmacol; 1990 Nov; 190(1-2):11-21. PubMed ID: 1963846 [TBL] [Abstract][Full Text] [Related]
31. Modulation of the discriminative stimulus and rate-altering effects of cocaine by competitive and noncompetitive N-methyl-D-aspartate antagonists. Kantak KM; Edwards MA; O'Connor TP Pharmacol Biochem Behav; 1998 Jan; 59(1):159-69. PubMed ID: 9443551 [TBL] [Abstract][Full Text] [Related]
32. Strychnine-insensitive glycine receptors in embryonic chick retina: characteristics and modulation of NMDA neurotoxicity. Boje KM; Skolnick P; Raber J; Fletcher RT; Chader G Neurochem Int; 1992 Jun; 20(4):473-86. PubMed ID: 1339019 [TBL] [Abstract][Full Text] [Related]
33. Competitive and non-competitive NMDA receptor antagonists induce c-Fos expression in the rat anterior, cingulate cortex. Wedzony K; Czyrak A J Physiol Pharmacol; 1996 Sep; 47(3):525-33. PubMed ID: 8877908 [TBL] [Abstract][Full Text] [Related]
34. Chronic glycine treatment desensitizes the behavioral response to 1-aminocyclopropanecarboxylic acid (ACPC), a partial agonist at the strychnine-insensitive glycine site of the NMDA receptor complex. Nowak G; Li Y; Paul IA J Neural Transm (Vienna); 2000; 107(2):123-31. PubMed ID: 10847554 [TBL] [Abstract][Full Text] [Related]
35. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors. Wong CS; Cherng CH; Luk HN; Ho ST; Tung CS Eur J Pharmacol; 1996 Feb; 297(1-2):27-33. PubMed ID: 8851162 [TBL] [Abstract][Full Text] [Related]
36. Biphenyl-derivatives of 2-amino-7-phosphonoheptanoic acid, a novel class of potent competitive N-methyl-D-aspartate receptor antagonist--I. Pharmacological characterization in vitro. Urwyler S; Laurie D; Lowe DA; Meier CL; Müller W Neuropharmacology; 1996 Jun; 35(6):643-54. PubMed ID: 8887974 [TBL] [Abstract][Full Text] [Related]
37. A competitive antagonist of NMDA receptors CGP 40116 attenuates experimental symptoms of schizophrenia evoked by MK-801. Zajaczkowski W; Czyrak A; Wedzony K Pol J Pharmacol; 2003; 55(5):703-11. PubMed ID: 14704466 [TBL] [Abstract][Full Text] [Related]
38. Sustained exposure to a glycine receptor partial agonist differentially alters NMDA receptor agonist and antagonist potencies in cultured spinal cord neurons. Lin Y; Fossom LH; Skolnick P; Long JB Eur J Pharmacol; 1998 Sep; 356(2-3):255-60. PubMed ID: 9774257 [TBL] [Abstract][Full Text] [Related]
39. NMDA/glutamate mechanism of magnesium-induced anxiolytic-like behavior in mice. Poleszak E; Wlaź P; Wróbel A; Fidecka S; Nowak G Pharmacol Rep; 2008; 60(5):655-63. PubMed ID: 19066411 [TBL] [Abstract][Full Text] [Related]
40. Sustained exposure to 1-aminocyclopropanecarboxylic acid, a glycine partial agonist, alters N-methyl-D-aspartate receptor function and subunit composition. Fossom LH; Basile AS; Skolnick P Mol Pharmacol; 1995 Dec; 48(6):981-7. PubMed ID: 8848014 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]